Tag: chronic respiratory disease
Inogen OK’d to supply airway clearance device
December 30, 2024HME News Staff
GOLETA, Calif. – Inogen has received 510(k) clearance from the U.S. Food and Drug Administration for the Simeox 200 Airway Clearance Device, expanding the company’s ability to market and meet the various needs of patients with chronic respiratory diseases in the U.S.
Inogen entered into a definitive agreement to acquire Physio-Assist SAS, a privately held company based in France that makes the technology-enabled Simeox for $32 million in 2023.
“We are very...
airway clearance, chronic respiratory disease, COPD, FDA clearance, Inogen, Simeox
Sponsored Stories
From Intake to Billing — SOS Handles It All for HME/DME Providers
By Strategic Office SupportHow Advanced Diabetes Supply is Driving Value-Based Health Outcomes
By Advanced Diabetes SupplySOS Achieves Remarkable 400% Growth in 2023, Bolsters Team with Director Appointment
By Strategic Office Support